Anaphylaxis and hypersensitivity reactions remain one of the most critical safety challenges in SACT delivery. This article explores how iQemo supports clinical teams in aligning with the latest UK SACT Board guidance through structured documentation, real-time alerts, and workflow visibility. Discover how these features help oncology teams strengthen patient safety from prescribing to administration
Read moreSign-up to the newsletter
iQ HealthTech have signed a 10 year contract with Healthcare at Home to supply iQemo as their chosen electronic chemotherapy prescribing system.
Read moreSign up to our newsletter and stay updated with industry-leading advice, insight and more…